Post-approval studies (Phase 4)Study completedNCT01023672What this trial is testing"Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"Who this might be right forDementia With Lewy Bodies Mayo Clinic 20
Not applicableStudy completedNCT07609537What this trial is testingImagery Control Therapy and Lucid Dreaming for REM-Related Symptoms in NarcolepsyWho this might be right forNarcolepsy Type 1Hypnagogic HallucinationsSleep Paralysis+2 more Institute of Behavioral Sleep Medicine, Colombia 98
Not applicableEnrolling By InvitationNCT05371483What this trial is testingCardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their TreatmentsWho this might be right forNarcolepsyIdiopathic Hypersomnia Mayo Clinic 100
Not applicableWithdrawnNCT00393562What this trial is testingComparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's DiseaseWho this might be right forParkinson's Disease US Department of Veterans Affairs
Not applicableStudy completedNCT06251063What this trial is testingImproving Social Relationships for Adolescents With Central Disorders of HypersomnolenceWho this might be right forNarcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia Boston Children's Hospital 25
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Testing effectiveness (Phase 2)Study completedNCT03772314What this trial is testingModafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic HypersomniaWho this might be right forIdiopathic HypersomniaNarcolepsy Without Cataplexy Emory University 44
Large-scale testing (Phase 3)Looking for participantsNCT07598708What this trial is testingInvestigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of HypersomnolenceWho this might be right forNarcolepsy Type 1Narcolepsy Type 2 Centessa Pharmaceuticals (UK) Limited 222